1/72
Comprehensive practice vocabulary flashcards covering adult echocardiography guidelines, valvular stenosis and regurgitation (pulmonic, tricuspid, aortic, mitral), primary and unclassified cardiomyopathies, diastolic function grading, pulmonary hypertension hemodynamics, and prosthetic valve evaluation.
Pulmonic Stenosis (PS)
Narrowing along the right ventricular outflow tract (RVOT) to the pulmonary arteries that impedes forward systolic blood flow; categorized anatomically as valvular (most common, usually congenital), subvalvular (infundibular), or supravalvular.

Pulmonic Valve M-Mode "a" Dip
An exaggerated late-diastolic dip of the pulmonic valve leaflet on M-mode (≥8mm) caused by elevated right ventricular end-diastolic pressure and vigorous atrial contraction in pulmonic stenosis.
Continuity Equation for Pulmonic Valve Area (PVA)
Formula estimating pulmonic orifice area: PVA=PV VTI0.785×(RVOTd)2×RVOT VTI, where normal resting PVA is 3.5–4.5cm2 and normal peak velocity is 0.6–0.9m/s.
Infundibular Pulmonary Stenosis (IPS)
Subvalvular obstruction within the muscular body of the right ventricular outflow tract, rarely isolated and commonly associated with a ventricular septal defect (VSD), resulting in right ventricular pressure overload and potential right-to-left shunting through an interatrial communication.
Mitral Regurgitation (MR)
Retrograde flow of blood from the left ventricle into the left atrium during ventricular systole due to incomplete closure or structural failure of the mitral valve apparatus.
Acute vs. Chronic Mitral Regurgitation Pathophysiology
Acute MR delivers a sudden, non-adapted regurgitant volume into a small, noncompliant left atrium causing rapid left atrial pressure elevation and acute pulmonary edema; chronic MR allows progressive left atrial dilation and eccentric left ventricular hypertrophy to maintain forward cardiac output.
Vena Contracta Width (MR)
The narrowest portion of the regurgitant jet immediately downstream of the orifice, measured perpendicular to jet direction in a zoomed view; values <0.3cm indicate mild MR, 0.3–0.69cm indicate moderate MR, and ≥0.7cm indicate severe MR.
PISA Method (Proximal Isovelocity Surface Area)
Quantitative color Doppler technique based on concentric hemispheric flow convergence: Flow Rate=2πr2×Va, EROA=VmaxFlow Rate, and Regurgitant Volume=EROA×MR VTI.
Severe Mitral Regurgitation Criteria (ASE)
Diagnostic cutoffs including a flail leaflet, vena contracta width ≥0.7cm, PISA radius ≥1.0cm (at Nyquist 30–40cm/s), EROA≥0.40cm2, RVol≥60mL, RF≥50%, or systolic flow reversal in the pulmonary veins.
MitraClip
A minimally invasive transcatheter device delivered via femoral venous access and transseptal puncture into the left atrium to grasp and approximate the anterior and posterior mitral leaflets, creating a double orifice to reduce regurgitation.
Tricuspid Stenosis (TS)
Narrowing of the tricuspid valve orifice that restricts diastolic filling from the right atrium to the right ventricle, most commonly caused by rheumatic heart disease (coexisting with mitral stenosis) or carcinoid syndrome.
Tricuspid Valve Area by Pressure Half-Time (PHT)
Estimated valve area calculated as TVA=PHT190; severe tricuspid stenosis is defined by PHT≥190ms, mean pressure gradient ≥5mmHg, and TVA<1.0cm2.
Carcinoid Heart Disease
Valvular pathology caused by circulating vasoactive substances (including serotonin) released by a neuroendocrine tumor, resulting in fibrous endocardial plaque deposition that produces thickened, retracted, and rigid ("frozen") right-sided valve leaflets.
Respiratory Variation of Tricuspid Inflow
Normal physiological fluctuation of approximately 10% where tricuspid inflow velocity increases during inspiration due to augmented systemic venous return and decreases during expiration.
Aortic Valve Stenosis Hemodynamic Grading
Classification of valvular aortic stenosis: Mild (Vmax2.6–2.9m/s, mean gradient <20mmHg, AVA>1.5cm2); Moderate (Vmax3.0–4.0m/s, mean gradient 20–40mmHg, AVA1.0–1.5cm2); Severe (Vmax≥4.0m/s, mean gradient ≥40mmHg, AVA≤1.0cm2, indexed AVA<0.6cm2/m2, DVI<0.25).
Continuity Equation for Aortic Valve Area (AVA)
Method based on conservation of mass assuming equal stroke volume through the LVOT and aortic valve: AVA=VTIAVCSALVOT×VTILVOT=VTIAV0.785×(LVOTd)2×VTILVOT.

Bicuspid Aortic Valve (BAV)
Congenital cardiac malformation characterized by fusion of two aortic cusps (most commonly the right and left coronary cusps with an intervening raphe), presenting on M-mode with an eccentric diastolic coaptation line (eccentricity index ≥1.5) and a football-shaped systolic orifice in short axis.
Classic Low-Flow, Low-Gradient Aortic Stenosis
Severe aortic stenosis presentation characterized by AVA≤1.0cm2, peak velocity <4.0m/s, mean gradient <40mmHg, stroke volume index <35mL/m2, and reduced LVEF<50%, evaluated with dobutamine stress echocardiography to differentiate true-severe from pseudo-severe stenosis.
Paradoxical Low-Flow, Low-Gradient Aortic Stenosis
Severe aortic stenosis occurring despite preserved LVEF≥50%, defined by AVA≤1.0cm2, peak velocity <4.0m/s, mean gradient <40mmHg, and stroke volume index <35mL/m2, typically seen in elderly hypertensive patients with small, hypertrophied left ventricles.
Doppler Velocity Index (DVI)
Dimensionless ratio expressing effective orifice area as a proportion of the LVOT: DVI=VAVVLVOT or VTIAVVTILVOT, where a value <0.25 corresponds to severe stenosis independent of LVOT diameter measurement errors.
Mitral Stenosis (MS)
Obstruction of diastolic blood flow from the left atrium into the left ventricle across a narrowed mitral valve orifice, resulting in an elevated transmitral diastolic pressure gradient, left atrial enlargement, and secondary pulmonary hypertension.

Rheumatic Mitral Stenosis 2D Sign
Diastolic doming of the anterior mitral valve leaflet in the parasternal long-axis view creating a classic "hockey-stick" contour, caused by commissural fusion and restricted leaflet edge excursion with preserved body pliability.
Pressure Half-Time (PHT) for Mitral Valve Area
The time in milliseconds required for the peak transmitral diastolic pressure gradient to decline by half, utilized to derive valve area via MVA=PHT220; severe MS corresponds to PHT≥220ms and MVA<1.0cm2.
Wilkins Score
Echocardiographic scoring system (ranging from 4 to 16 points) grading mitral leaflet mobility, leaflet thickening, subvalvular thickening, and calcification; a total score ≤8 predicts favorable procedural success for percutaneous balloon mitral valvotomy.
Spontaneous Echo Contrast (SEC)
Dynamic smoke-like swirling echogenicity seen on echocardiography in the left atrium or left atrial appendage, caused by red blood cell aggregation in low-velocity blood stasis that serves as a precursor to thrombus formation.
Aortic Regurgitation (AR)
Incompetence of the aortic valve resulting in retrograde diastolic blood flow from the aorta into the left ventricle, caused by cuspal pathology, aortic root dilation, or root distortion.
Austin Flint Murmur
A low-pitched mid-to-late diastolic rumble heard at the cardiac apex in severe aortic regurgitation, generated when the regurgitant jet impinges upon the anterior mitral leaflet, causing functional inflow restriction and vibration.
Premature Mitral Valve Closure
Abnormal early coaptation of the mitral valve on or before the onset of the electrocardiographic QRS complex, caused by a precipitous rise in left ventricular end-diastolic pressure in acute severe aortic regurgitation.
Aortic Regurgitation Pressure Half-Time (PHT)
Continuous-wave Doppler measurement of the rate of pressure equalization between the aorta and LV; a steep deceleration slope with PHT<200ms indicates severe AR, whereas a flat slope with PHT>500ms reflects mild AR.
Holodiastolic Flow Reversal in the Descending Aorta
Retrograde pulsed-wave Doppler flow persisting throughout the entire diastolic cycle in the thoracic descending aorta with an end-diastolic velocity >20cm/s, indicative of severe aortic regurgitation.
Dilated Cardiomyopathy (DCM)
Myocardial disease defined by progressive ventricular chamber dilation, wall thinning, and impaired global systolic contraction (LVEF<45%) in the absence of abnormal loading conditions sufficient to cause the dysfunction.
Sphericity Index
The ratio of the left ventricular long-axis length to short-axis diameter, where a value <1.5 indicates pathological spherical geometric remodeling and worsening global systolic performance.
E-Point Septal Separation (EPSS)
The distance between the maximal anterior excursion of the anterior mitral leaflet (E-point) and the ventricular septum on M-mode; increased separation reflects left ventricular chamber dilation and diminished stroke volume.
Mitral Valve "B" Bump
An M-mode contour abnormality demonstrating delayed leaflet coaptation and an elevated notch between the A and C points, signaling markedly increased left ventricular end-diastolic pressure (≥15–20mmHg).
Rate of LV Pressure Rise (dP/dt)
Index of isovolumic left ventricular contractility calculated from the continuous-wave MR velocity envelope between 1m/s and 3m/s: dP/dt=Δt32×1000, where normal values exceed 1200mmHg/s and abnormal values are <1000mmHg/s.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/ARVD)
Genetic cardiomyopathy characterized by fibrofatty replacement of right ventricular myocardium, leading to right ventricular dilation, localized free-wall aneurysms, a hyperreflective moderator band, ventricular arrhythmias, and sudden cardiac death.
Takotsubo Cardiomyopathy
Stress-induced neurogenic cardiomyopathy ("broken heart syndrome") predominantly affecting postmenopausal women, characterized by transient left ventricular apical and mid-ventricular ballooning and akinesis with basal hyperkinesis triggered by a catecholamine surge.
Left Ventricular Noncompaction (LVNC)
Congenital cardiomyopathy caused by arrest of normal myocardial compaction during embryogenesis, presenting with prominent trabeculations, deep intertrabecular recesses, and an end-diastolic noncompacted-to-compacted myocardial thickness ratio (NC/C) >2.0 in adults.
Chagas Cardiomyopathy
Infectious non-ischemic cardiomyopathy caused by Trypanosoma cruzi (transmitted by the kissing bug), manifested by chronic fibrosing myocarditis, left and right ventricular apical aneurysms, high thromboembolic risk, and classic segmental wall motion abnormalities of the inferolateral and lateral LV walls.
Pulmonic Regurgitation (PR)
Retrograde diastolic blood flow from the pulmonary artery into the right ventricle through an incompetent pulmonic valve, most frequently secondary to pulmonary arterial hypertension or primary structural abnormalities following congenital heart defect repairs.
Graham-Steell Murmur
A high-pitched, blowing early diastolic decrescendo murmur heard along the left upper sternal border caused by high-velocity pulmonary regurgitation occurring in the presence of severe pulmonary arterial hypertension.
Pulmonary Artery End-Diastolic Pressure (PAEDP)
Diastolic pulmonary pressure estimated from end-diastolic pulmonary regurgitation velocity (VPR-end) using the formula: PAEDP=4×(VPR-end)2+RAP, with a normal range of 4–12mmHg.
Mean Pulmonary Artery Pressure (mPAP) Doppler Estimations
Calculation derived from the peak early-diastolic PR velocity (mPAP=4×(VPR-early)2+RAP) or from the RVOT pulsed-wave acceleration time (mPAP=79−[0.45×RVAT]), with normal values ranging from 8–20mmHg.
Diastolic Dysfunction
Pathological state in which the ventricular myocardium exhibits impaired active relaxation, reduced passive compliance, and increased stiffness, requiring elevated filling pressures to achieve adequate diastolic filling.
Grade I Diastolic Dysfunction (Impaired Relaxation)
Mild diastolic impairment characterized by delayed early LV relaxation with normal filling pressures: E/A≤0.8, deceleration time >240ms, IVRT>90ms, average E/e′<10, and pulmonary vein S≥D.
Grade II Diastolic Dysfunction (Pseudonormal)
Moderate diastolic dysfunction where elevated left atrial pressure masks delayed relaxation, creating a baseline E/A of 0.8–2.0 that reverses to an impaired relaxation pattern (E/A<0.8) during the strain phase of the Valsalva maneuver.
Grade III Diastolic Dysfunction (Restrictive Filling)
Severe diastolic dysfunction characterized by marked myocardial noncompliance and severe filling pressure elevation: E/A>2.0, deceleration time <140–160ms, IVRT<60–70ms, average E/e′≥14, and pulmonary vein S<D.
Tissue Doppler Early Diastolic Velocity (e′)
Measurement of longitudinal early diastolic myocardial relaxation at the mitral annulus; values are considered abnormally depressed when septal e′≤6cm/s or lateral e′≤7cm/s.
Restrictive Cardiomyopathy (RCM)
Myocardial disorder marked by rigid, noncompliant ventricular walls that severely restrict diastolic filling while preserving global systolic ejection fraction (HFpEF), characteristically presenting with biatrial enlargement and normal ventricular cavity dimensions.
Cardiac Amyloidosis
Infiltrative cardiomyopathy caused by extracellular deposition of amyloid protein fibrils, displaying granular "ground glass" myocardial speckling, biatrial enlargement, low QRS voltage on ECG despite thick walls, reduced TDI velocities (<5cm/s), and apical sparing on strain imaging.

Apical Sparing Strain Pattern
Specific 2D speckle-tracking strain polar ("bull's-eye") pattern in cardiac amyloidosis showing preserved longitudinal strain at the left ventricular apex with markedly diminished strain in the mid and basal segments ("cherry-on-top").
Pulmonary Hypertension (PH) Diagnostic Definition
Hemodynamic condition confirmed by right heart catheterization as a resting mean pulmonary artery pressure (mPAP) >20mmHg; classified into five clinical groups based on etiology.
Right Ventricular Systolic Pressure (RVSP)
Echocardiographic estimation of pulmonary artery systolic pressure calculated via RVSP=4×(Vmax TR)2+RAP; values ≤34mmHg are normal, 35–49mmHg are mildly elevated, 50–69mmHg are moderately elevated, and ≥70mmHg are severely elevated.
Inferior Vena Cava (IVC) Method for Right Atrial Pressure
Ultrasound sizing of the subcostal IVC and collapse percentage: IVC≤2.1cm with ≥50% inspiratory collapse estimates an RAP of 3mmHg; IVC>2.1cm with <50% collapse estimates 15mmHg; intermediate parameters yield 8mmHg; and dilated IVC without collapse yields 20mmHg.
Cor Pulmonale
Right ventricular enlargement, hypertrophy, or failure resulting from primary disorders of the respiratory system or pulmonary vasculature; categorized as acute (e.g., massive pulmonary embolism) or chronic (e.g., COPD).

McConnell's Sign
Echocardiographic regional right ventricular free-wall wall motion abnormality characteristic of acute pulmonary embolism, defined by akinesis of the mid and basal segments with preserved or hyperdynamic contraction of the apex.

Pulmonary Valve M-Mode in Pulmonary Hypertension ("Flying W")
An M-mode pattern of the posterior pulmonic valve leaflet showing mid-systolic closure or notching caused by an abrupt mid-systolic deceleration of forward flow and elevated pulmonary vascular resistance.
Tricuspid Annular Plane Systolic Excursion (TAPSE)
M-mode quantification of right ventricular longitudinal systolic function measured by the displacement of the lateral tricuspid annulus toward the apex, where a value ≤17mm indicates right ventricular systolic dysfunction.
Mechanical vs. Bioprosthetic Heart Valves
Mechanical prostheses (bileaflet, tilting disc, caged-ball) offer exceptional long-term structural durability over decades but require lifelong warfarin anticoagulation; bioprosthetic tissue valves (bovine pericardial, porcine, homografts) avoid obligatory lifelong anticoagulation but are prone to structural deterioration in 10–15years.

Mechanical Bileaflet Valve
The most widely implanted mechanical valve prosthesis (such as St. Jude Medical), comprising two semicircular pyrolytic carbon discs pivoting within a rigid ring that create two lateral orifices and one narrow central orifice.
Prosthetic Valve Dehiscence
Separation of the prosthetic sewing ring from the native annular bed due to mechanical stress or infective endocarditis, demonstrated by abnormal independent "rocking" motion of the prosthesis and significant paravalvular regurgitation.
Pannus vs. Thrombus in Prosthetic Valves
Pannus is dense, slow-growing, echogenic fibroelastic hyperplasia extending from the annular margins; thrombus is soft, larger, mobile clot formation typically associated with subtherapeutic anticoagulation.
Ross Procedure
Surgical autograft procedure in which a diseased native aortic valve is replaced with the patient's own pulmonary valve autograft, and a pulmonary homograft (cadaveric allograft) is implanted in the pulmonary position.

Edwards SAPIEN Transcatheter Valve
A balloon-expandable transcatheter heart valve composed of bovine pericardial tissue mounted inside a cobalt-chromium or stainless-steel stent with a polyethylene terephthalate skirt, implanted percutaneously to treat severe aortic stenosis.
WATCHMAN Device
A percutaneously implanted transcatheter occlusion device placed in the left atrial appendage to prevent intra-appendage thrombus embolization and stroke in patients with nonvalvular atrial fibrillation who have contraindications to long-term oral anticoagulation.
Secondary (Functional) Tricuspid Regurgitation
Incompetence of structurally normal tricuspid valve leaflets caused by annular dilation and leaflet tethering from right ventricular pressure/volume overload or chronic right atrial enlargement.

Hepatic Vein Systolic Flow Reversal
Pulsed-wave Doppler finding in the hepatic veins where the normal forward systolic S wave is reversed into a retrograde flow wave, representing a highly specific marker for severe tricuspid regurgitation.
Paradoxical Septal Motion (RVVO)
Abnormal motion of the interventricular septum resulting from right ventricular volume overload, characterized by diastolic flattening of the septum into the left ventricle (creating a D-shaped LV in diastole) followed by anterior systolic motion.
Hypertrophic Cardiomyopathy (HCM)
Genetic myocardial disorder inherited in an autosomal dominant pattern caused by mutations in sarcomere protein genes, characterized by localized or generalized LV hypertrophy (wall thickness ≥15mm, or 13–14mm in first-degree relatives) in the absence of secondary loading conditions.
Systolic Anterior Motion (SAM)
Abnormal systolic displacement of the anterior mitral valve leaflet toward the hypertrophied interventricular septum driven by the Venturi effect and hydrodynamic drag forces, precipitating dynamic LVOT obstruction and posteriorly directed eccentric mitral regurgitation.

Dagger-Shaped LVOT Waveform
Late-peaking, high-velocity continuous-wave Doppler envelope across the left ventricular outflow tract in obstructive hypertrophic cardiomyopathy, produced as dynamic obstruction progressively worsens throughout mid-to-late systole.
Provocative Maneuvers in HCM
Physiological or pharmacological techniques (Valsalva maneuver strain phase, standing, exercise, amyl nitrite) that decrease LV preload or afterload, reducing chamber size and unmasking or augmenting dynamic LVOT gradients and systolic murmurs.
Mavacamten
First-in-class cardiac myosin inhibitor approved for adults with symptomatic NYHA class II–III obstructive hypertrophic cardiomyopathy that modulates the number of active myosin heads binding to actin, reducing dynamic LVOT obstruction and improving filling pressures.